2017 Press Releases

Receive E-mail AlertsE-mail Alerts

Webcast ImageWebcast
Geron at Stifel 2017 Healthcare Conference (Replay)
11/14/17
Geron at Stifel 2017 Healthcare Conference
Tuesday, November 14, 2017 
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Geron at Piper Jaffray 29th Annual Healthcare Conference  (Live)
11/28/17
Geron at Piper Jaffray 29th Annual Healthcare Conference
Tuesday, November 28, 2017 
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
Nov 20, 2017Geron Announces First Patient Dosed in Expanded Part 1 of IMerge Clinical Trial in Myelodysplastic Syndromes
MENLO PARK, Calif., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that the first patient has been dosed in the expanded Part 1 of IMerge, the ongoing Phase 2/3 clinical trial of imetelstat in transfusion dependen... 
Printer Friendly Version
Nov 7, 2017Geron Announces November Investor Conference Presentation Webcasts
MENLO PARK, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at the following investor conferences: Stifel 2... 
Printer Friendly Version
Nov 1, 2017Geron Corporation Reports Third Quarter 2017 Financial Results
MENLO PARK, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the three and nine months ended September 30, 2017. For the third quarter of 2017, the company reported a net loss of $6.9 m... 
Printer Friendly Version
Nov 1, 2017Geron Announces Presentations at American Society of Hematology Annual Meeting
Imetelstat Clinical Data from Part 1 of IMerge in Myelodysplastic Syndromes to be Presented MENLO PARK, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that four abstracts related to the telomerase inhibit... 
Printer Friendly Version
Oct 31, 2017Geron Announces Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic Syndromes
Expanded Part 1 of IMerge is Open for Patient Enrollment MENLO PARK, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that the United States Food and Drug Administration (FDA) has granted Fast Track designa... 
Printer Friendly Version
Oct 25, 2017Geron Announces Conference Call to Discuss Third Quarter 2017 Financial Results
MENLO PARK, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the third quarter ended September 30, 2017, on Wednesday, November 1, 2017, after the market close. Geron’s management wil... 
Printer Friendly Version
Sep 19, 2017Geron to Present at the Cantor Fitzgerald Healthcare Conference
MENLO PARK, Calif., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at the Cantor Fitzgerald Global Healthcare Conference... 
Printer Friendly Version
Aug 9, 2017Geron Corporation Reports Second Quarter 2017 Financial Results
MENLO PARK, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the three and six months ended June 30, 2017. For the second quarter of 2017, the company reported a net loss of $6.4 mill... 
Printer Friendly Version
Jul 31, 2017Geron Announces Updates to Imetelstat Clinical Development
Conference Call Scheduled for 8:00 a.m. ET on Tuesday, August 1 MENLO PARK, Calif., July 31, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced updates to the clinical development plans for IMerge and IMbark, the ongoing tria... 
Printer Friendly Version
May 9, 2017Geron Corporation Reports First Quarter 2017 Financial Results and Recent Events
MENLO PARK, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the first quarter ended March 31, 2017 and recent events. First Quarter 2017 Results For the first quarter of 2017, the co... 
Printer Friendly Version
Apr 25, 2017Geron 2017 Annual Meeting of Stockholders to be Held on May 9
First Quarter 2017 Financial Results Expected Same Day MENLO PARK, Calif., April 25, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will hold its 2017 Annual Meeting of Stockholders, on Tuesday, May 9, 2017, at 4:00 p.m. PDT. Geron’s ... 
Printer Friendly Version
Apr 10, 2017Geron Announces Completion of Second Internal Data Reviews for Imetelstat Trials Being Conducted by Janssen
Both IMerge and IMbark Continue in Lower Risk Myelodysplastic Syndromes and Relapsed or Refractory Myelofibrosis Conference Call Scheduled for 8:00 a.m. EDT Today, April 10 MENLO PARK, Calif., April 10, 2017 (GLOBE NEWSWIRE) -- Geron Corporatio... 
Printer Friendly Version
Apr 9, 2017Geron Announces Conference Call on April 10 at 8:00 A.M. Eastern Time
MENLO PARK, Calif., April 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will host a conference call on April 10, 2017, at 8:00 a.m. Eastern Time to provide an update on the ongoing imetelstat Phase 2/3 trial in myelodysplastic syndro... 
Printer Friendly Version
Apr 5, 2017Geron Reports Imetelstat Presentation at American Association for Cancer Research Annual Meeting
MENLO PARK, Calif., April 05, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced a poster presentation by Janssen Research & Development, LLC describing non-clinical data on the telomerase inhibitor imetelstat at the 2017 ... 
Printer Friendly Version
Mar 2, 2017Geron Announces Presentation at American Association for Cancer Research Annual Meeting
MENLO PARK, Calif., March 02, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced an abstract submitted by Janssen Research & Development, LLC describing non-clinical data on imetelstat has been accepted for presentation as... 
Printer Friendly Version
Mar 1, 2017Geron Corporation Reports Fourth Quarter and Annual 2016 Financial Results
Conference Call Scheduled for 4:30 p.m. ET Today, March 1 MENLO PARK, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the fourth quarter and year ended December 31, 2016 and recent ev... 
Printer Friendly Version
Feb 22, 2017Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2016 Financial Results
MENLO PARK, Calif., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the fourth quarter and year ended December 31, 2016, on Wednesday, March 1, 2017, after the market close. Geron’s manageme... 
Printer Friendly Version
 Print Page |  E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts